Clifford Group’s Thermo Fisher Scientific TMO Stock Holding History

Clifford Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$217K	Sell	441 -47	-10%	-$25.5K	0.17%	75
2025 Q4	$283K	Sell	488 -9	-2%	-$5.09K	0.22%	59
2025 Q3	$241K	Hold	497	–	–	0.19%	75
2025 Q2	$202K	Sell	497 -20	-4%	-$8.36K	0.17%	83
2025 Q1	$257K	Buy	517 +27	+6%	+$14.6K	0.24%	62
2024 Q4	$255K	Sell	490 -2	-0.4%	-$1.1K	0.19%	66
2024 Q3	$304K	Sell	492 -26	-5%	-$15.4K	0.24%	63
2024 Q2	$286K	Hold	518	–	–	0.23%	62
2024 Q1	$301K	Buy	518 +2	+0.4%	+$1.12K	0.25%	58
2023 Q4	$274K	Sell	516 -32	-6%	-$15.5K	0.25%	62
2023 Q3	$277K	Sell	548 -7	-1%	-$3.73K	0.3%	57
2023 Q2	$290K	Buy	555 +6	+1%	+$3.24K	0.31%	57
2023 Q1	$316K	Hold	549	–	–	0.38%	54
2022 Q4	$302K	Buy	+549	New	+$291K	0.38%	61

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Clifford Group's TMO Position: Q1 2026 in Review

Clifford Group reduced its Thermo Fisher Scientific (TMO) stake by 9.6% in Q1 2026, selling an estimated $25.5K and leaving 441 shares worth $217K. The position accounts for 0.17% of the portfolio, ranked #75.

Clifford Group first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $316K in Q1 2023. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Clifford Group held 441 shares of Thermo Fisher Scientific worth $217K as of Q1 2026.
Clifford Group sold 47 Thermo Fisher Scientific shares in Q1 2026, an estimated $25.5K.
Thermo Fisher Scientific made up 0.17% of Clifford Group's portfolio in Q1 2026, its #75 holding.
Clifford Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
Clifford Group's Thermo Fisher Scientific position peaked at $316K in Q1 2023.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Clifford Group's 13F filing for Q1 2026, filed 15 May 2026.